EICOSIS
EicOsis is developing inhibitors to a the soluble epoxide hydrolase, a key regulatory enzyme involved in the metabolism of fatty acids, to treat unmet medical needs in human and animals.sEH inhibitors treat pain by stabilizing natural analgesic and anti-inflammatory mediators.
EICOSIS
Industry:
Biotechnology Health Care
Founded:
2011-01-01
Address:
Davis, California, United States
Country:
United States
Website Url:
http://www.eicosis.com
Total Employee:
11+
Status:
Active
Contact:
650 455 0388
Email Addresses:
[email protected]
Total Funding:
5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Founder
Official Site Inspections
http://www.eicosis.com
- Host name: 67-222-42-233.unifiedlayer.com
- IP address: 67.222.42.233
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "EicOsis"
Home - EicOsis
EicOsis recently published the results for two Phase 1a clinical trials in healthy volunteers. The trials evaluated the safety and pharmacokinetic profile of EC5026 in a single-ascending dose …See details»
EicOsis - Crunchbase Company Profile & Funding
EicOsis is developing inhibitors to a the soluble epoxide hydrolase, a key regulatory enzyme involved in the metabolism of fatty acids, to treat unmet medical needs in human and animals.sEH inhibitors treat pain by stabilizing …See details»
Investors - EicOsis
EicOsis is a privately held company developing a first-in-class therapy for neuropathic and inflammatory pain in humans and companion animals. The technology for the lead compounds was developed largely at the University of …See details»
EicOsis - LinkedIn
EicOsis is a small start-up company located in Davis, CA focused on developing non-opioid treatments for pain in humans and animals.See details»
Media & Investors - EicOsis
EicOsis is Developing a Better Option for Pain and Inflammation. At EicOsis, we recognize the needs of those living with pain and inflammatory conditions. We are developing a completely …See details»
Davis-Based Company Targeting Chronic Pain Gets Financial Boost
Apr 22, 2019 DAVIS--EicOsis LLC, a Davis-based company seeking to block chronic pain in humans and companion animals, has received a $5 million investment from Open …See details»
EicOsis Human Health Named One of Nation's Most …
Oct 6, 2024 Bruce Hammock, co-founder of EicOsis (Photo by Kathy Keatley Garvey) EicOsis Human Health, Inc., a clinical startup co-founded by UC Davis distinguished professor Bruce Hammock to alleviate chronic pain without the …See details»
EicOsis Human Health Named One of Nation's Most Fundable …
Oct 7, 2024 UC Davis doctoral alumna Cindy McReynolds, co-founder of EicOsis. Photo courtesy of UC Davis Department of Entomology and Nematology. SACRAMENTO, CA …See details»
EicOsis - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 18, 2019: Grant - EicOsis . …See details»
EicOsis Receives $15M to Help Fund Human Clinical Trials of Non …
By Lisa Howard October 16, 2019 EicOsis LLC, a UC Davis-enabled startup, announced yesterday (Oct. 15) it has been awarded a $15 million grant from the National Institute on Drug …See details»
EicOsis | Seed
EicOsis is developing a new approach to treat pain and inflammation by inhibiting the soluble Epoxide Hydrolase (sEH), a key regulatory enzyme. Inhibiting sEH increases the levels of …See details»
Good News About Chronic Pain Relief That Began with Caterpillar ...
Jan 30, 2024 Good news! EicOsis Human Health LLC, the Davis-based pharmaceutical company developing a non-narcotic drug to relieve chronic pain and inflammation, today …See details»
EicOsis - Overview, News & Similar companies | ZoomInfo.com
EicOsis Announces First Subject Dosed in Phase 1a Clinical Trial of EC5026 EicOsis LLC, a pharmaceutical startup developing a new class of oral non-narcotic analgesics based on …See details»
EicOsis - Contacts, Employees, Board Members, Advisors & Alumni
EicOsis Human Health is devel oping a first-in-class therapy of a once dailySee details»
Robert Gregoire - Chief Business Officer at EicOsis | The Org
Robert Gregoire is an experienced CEO, founder, and board member with over 25 years of organizational leadership in diversified industries. He specializes in developing strategies, …See details»
Media - EicOsis
EicOsis is an innovation leader in the local community October 2024: EicOsis Among 2024 Most Fundable Companies. EicOsis has been selected as one of the 2024 Pepperdine Graziadio …See details»
EicOsis Human Health Company Profile 2024: Valuation, Funding ...
Jul 6, 2018 EicOsis Human Health is headquartered in Davis, CA. What is the size of EicOsis Human Health? EicOsis Human Health has 8 total employees. What industry is EicOsis …See details»
Human Health - EicOsis
EicOsis received IND clearance from the FDA for EC5026 in October 2019. Phase 1a clinical trials in human volunteers started in December 2019, showing a favorable safety and …See details»
EicOsis begins Phase Ib study of drug candidate EC5026
Jan 31, 2024 EicOsis Human Health has commenced a Phase Ib multiple-ascending dose clinical study of EC5026, the first soluble epoxide hydrolase inhibitor (sEHI) developed for the …See details»
Our Approach - EicOsis
EicOsis is developing a new class of oral drugs for human pain and inflammatory conditions. EC5026, our first candidate drug, is currently undergoing Phase 1 human clinical trials. Learn …See details»